Trials / Active Not Recruiting
Active Not RecruitingNCT06982846
A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
A Randomized, Placebo-Controlled, Parallel Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 78 (estimated)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to measure the effect of retatrutide versus placebo, administered every week, on time to recovery from hypoglycemia during hypoglycemic clamp in participants with Type 2 Diabetes Mellitus (T2DM) following 16 weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Retatrutide | Administered SC |
| DRUG | Placebo | Administered SC |
Timeline
- Start date
- 2025-06-06
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2025-05-21
- Last updated
- 2026-01-20
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT06982846. Inclusion in this directory is not an endorsement.